Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

Historical Holders from Q4 2015 to Q3 2025

Symbol
VYGR on Nasdaq
CUSIP
92915B106
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
55.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
30.2M
Holdings value
$141M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
114
Number of buys
51
Number of sells
-55
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 7.57% -22.8% $19.6M -$5.77M 4.2M -22.7% Armistice Capital, LLC Sep 30, 2025
EcoR1 Capital, LLC 6.8% $18.7M 4M EcoR1 Capital, LLC Sep 30, 2025
BlackRock, Inc. 6.4% $12.4M 3.53M BlackRock, Inc. Mar 31, 2025

Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 30.2M $141M -$12.5M $4.67 114
2025 Q2 33.2M $103M -$5.02M $3.11 107
2025 Q1 34.7M $117M -$2.38M $3.38 114
2024 Q4 34.6M $196M -$3.23M $5.67 130
2024 Q3 35M $205M -$20.2M $5.85 126
2024 Q2 38.1M $302M +$18.9M $7.91 126
2024 Q1 34.5M $321M +$80.4M $9.31 131
2023 Q4 25.9M $219M -$3.56M $8.44 107
2023 Q3 26.2M $203M +$537K $7.75 110
2023 Q2 25.8M $296M +$49M $11.45 105
2023 Q1 22.8M $175M -$69.4K $7.71 83
2022 Q4 22.9M $139M -$700K $6.10 68
2022 Q3 23M $136M +$348K $5.92 66
2022 Q2 22.9M $136M +$8.18M $5.91 73
2022 Q1 21.2M $162M +$28.9M $7.62 67
2021 Q4 17.6M $47.7M -$9.6M $2.71 51
2021 Q3 21.3M $56.1M -$4.61M $2.63 62
2021 Q2 22.7M $93.7M -$15.7M $4.13 71
2021 Q1 26.1M $123M -$6.91M $4.71 93
2020 Q4 27.3M $195M -$7.12M $7.15 93
2020 Q3 27.7M $296M -$21.2M $10.67 105
2020 Q2 29.5M $372M -$3.23M $12.62 106
2020 Q1 29.9M $274M -$8.84M $9.15 114
2019 Q4 30.5M $425M -$4.98M $13.95 132
2019 Q3 30.4M $523M +$3.41M $17.21 127
2019 Q2 29M $788M +$142M $27.22 122
2019 Q1 27.2M $520M +$3.42M $19.14 110
2018 Q4 27.8M $261M -$17.1M $9.40 112
2018 Q3 28.9M $547M -$4.05M $18.92 117
2018 Q2 29.1M $569M +$41.4M $19.54 125
2018 Q1 27.1M $509M +$37M $18.79 108
2017 Q4 25.2M $418M +$68.4M $16.60 98
2017 Q3 11.3M $233M +$24.1M $20.59 74
2017 Q2 10.9M $98.1M -$1.7M $8.96 51
2017 Q1 11.1M $146M +$8.71M $13.24 45
2016 Q4 11M $140M +$4.08M $12.74 54
2016 Q3 10.6M $128M +$782K $12.01 50
2016 Q2 10.6M $116M +$5.91M $10.99 48
2016 Q1 10M $87M -$3.38M $8.73 41
2015 Q4 10.4M $225M +$220M $21.90 35